S
Stephen E. Van Rompaey
Researcher at University of Washington
Publications - 28
Citations - 2891
Stephen E. Van Rompaey is an academic researcher from University of Washington. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Viral load. The author has an hindex of 19, co-authored 27 publications receiving 2630 citations. Previous affiliations of Stephen E. Van Rompaey include Johns Hopkins University.
Papers
More filters
Journal ArticleDOI
Effect of early versus deferred antiretroviral therapy for HIV on survival.
Mari M. Kitahata,Stephen J. Gange,Alison G. Abraham,Barry Merriman,Michael S. Saag,Amy C. Justice,Robert S. Hogg,Steven G. Deeks,Joseph J. Eron,John T. Brooks,Sean B. Rourke,M. John Gill,Ronald J. Bosch,Jeffrey N. Martin,Marina B. Klein,Lisa P. Jacobson,Benigno Rodriguez,Timothy R. Sterling,Gregory D. Kirk,Sonia Napravnik,Anita Rachlis,Liviana Calzavara,Michael A. Horberg,Michael J. Silverberg,Kelly A. Gebo,James J. Goedert,Constance A. Benson,Ann C. Collier,Stephen E. Van Rompaey,Heidi M. Crane,Rosemary G. McKaig,Bryan Lau,Aimee M. Freeman,Richard D. Moore +33 more
TL;DR: The early initiation of antiretroviral therapy before the CD4+ count fell below two prespecified thresholds significantly improved survival, as compared with deferred therapy.
Journal ArticleDOI
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems
Mari M. Kitahata,Benigno Rodriguez,Richard Haubrich,Stephen L. Boswell,W. Christopher Mathews,Michael M. Lederman,William B. Lober,Stephen E. Van Rompaey,Heidi M. Crane,Richard D. Moore,Michael J. Bertram,James O. Kahn,Michael S. Saag +12 more
TL;DR: The objective of the CNICS project is to integrate clinical data from the large and diverse population of HIV-infected persons receiving care at CFAR sites to investigate questions related to HIV disease management that cannot be readily addressed through traditional randomized controlled clinical trials and other cohort studies.
Journal ArticleDOI
Late Presentation for Human Immunodeficiency Virus Care in the United States and Canada
Keri N. Althoff,Stephen J. Gange,Marina B. Klein,John T. Brooks,Robert S. Hogg,Ronald J. Bosch,Michael A. Horberg,Michael S. Saag,Mari M. Kitahata,Amy C. Justice,Kelly A. Gebo,Joseph J. Eron,Sean B. Rourke,M. John Gill,Benigno Rodriguez,Timothy R. Sterling,Liviana Calzavara,Steven G. Deeks,Jeffrey N. Martin,Anita Rachlis,Sonia Napravnik,Lisa P. Jacobson,Gregory D. Kirk,Ann C. Collier,Constance A. Benson,Michael J. Silverberg,Margot Kushel,James J. Goedert,Rosemary G. McKaig,Stephen E. Van Rompaey,Jinbing Zhang,Richard D. Moore +31 more
TL;DR: CD4 count at first presentation for HIV care has increased annually over the past 11 years but has remained <350 cells/mm(3), which suggests the urgent need for earlier HIV diagnosis and treatment.
Journal ArticleDOI
Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.
TL;DR: Treatment with lopinavir/ritonavir is significantly associated with elevated BP, an effect that appears to be mediated through an increase in BMI, which will increasingly influence treatment decisions.
Journal ArticleDOI
End-Stage Renal Disease Among HIV-Infected Adults in North America
Alison G. Abraham,Keri N. Althoff,Yuezhou Jing,Michelle M. Estrella,Mari M. Kitahata,C. William Wester,Ronald J. Bosch,Heidi M. Crane,Joseph J. Eron,M. John Gill,Michael A. Horberg,Amy C. Justice,Amy C. Justice,Marina B. Klein,Angel M. Mayor,Richard D. Moore,Frank J. Palella,Chirag R. Parikh,Michael J. Silverberg,Elizabeth T. Golub,Lisa P. Jacobson,Sonia Napravnik,Gregory M. Lucas,Gregory D. Kirk,Constance A. Benson,Ann C. Collier,Stephen L. Boswell,Chris Grasso,Kenneth H. Mayer,Robert S. Hogg,Richard Harrigan,Julio S. G. Montaner,Angela Cescon,John T. Brooks,Kate Buchacz,Kelly A. Gebo,Benigno Rodriguez,Jennifer E. Thorne,James J. Goedert,Sean B. Rourke,Ann N. Burchell,Anita Rachlis,Robert F. Hunter-Mellado,Steven G. Deeks,Jeffrey N. Martin,Michael S. Saag,Michael J. Mugavero,James H. Willig,Robert Dubrow,David Fiellin,Timothy R. Sterling,David W. Haas,Sally Bebawy,Megan Turner,Stephen J. Gange,Kathryn Anastos,Rosemary G. McKaig,Aimee M. Freeman,Carol Lent,Stephen E. Van Rompaey,Eric Webster,Liz Morton,Brenda Simon,Bryan Lau,Jinbing Zhang,Shari Modur,David B. Hanna,Peter F Rebeiro,Cherise Wong,Adell Mendes +69 more
TL;DR: The risk of ESRD remains high among HIV-infected individuals in care but is declining with improvements in virologic suppression, coincident with notable increases in both the prevalence of viral suppression and the prevalenceof E SRD risk factors including diabetes mellitus, hypertension, and hepatitis C virus coinfection.